引用本文:申成霖, 张新鑫, 侯文华.制药产业创新激励政策研究的述评与展望[J].中国卫生政策研究,2017,10(8):34-39 |
|
制药产业创新激励政策研究的述评与展望 |
投稿时间:2016-12-10 修订日期:2017-06-01 PDF全文浏览 HTML全文浏览 |
申成霖1, 张新鑫2, 侯文华3 |
1. 天津工业大学管理学院 天津 300387; 2. 天津理工大学管理学院 天津 300384; 3. 南开大学商学院 天津 300071 |
摘要:基于制药产业激励与规制并存的典型特征,将制药产业创新激励政策划分为激励性政策和规制性政策两大类。通过国内外相关文献的梳理,就价格管制政策、医保支付政策、集中采购规制以及创新药研发激励政策对制药产业创新激励影响的研究进展进行了梳理和述评,提出未来该领域的研究应立足于中国的管理实践,从非对称信息、多种政策工具对创新药研发激励的综合作用机制,以及引入新的研究范式等三个方面进行突破。 |
关键词:制药产业 创新 激励 规制 政策 |
基金项目:国家社会科学基金项目(15BGL074);天津市哲学社会科学基金(TJGL15-035);天津市宣传文化"五个一批"人才项目(2015RC05) |
|
A study on innovation incentive policy of pharmaceutical industry in China:A review |
SHEN Cheng-lin1, ZHANG Xin-xin2, HOU Wen-hua3 |
1. School of Management of Tianjin Polytechnic University, Tianjin 300387, China; 2. School of Management of Tianjin University of Technology, Tianjin 300384, China; 3. School of Business of Nankai University, Tianjin 300071, China |
Abstract:Based on the typical characteristics of existing incentive and regulation in the pharmaceutical industry in China, the innovation incentive policy of the pharmaceutical industry can be divided into two types:incentive policy, and regulatory policy. This paper reviewed the research progress on the influence of price regulation policy, health insurance payment policy, centralized procurement regulation and incentive policy on the innovation of pharmaceutical industry. The present paper puts also forward the future research direction. Based on the literature review, it has been found that the future researches in this field should be based on the management practice situation in China, and make a breakthrough from the following three aspects-asymmetric information, comprehensive action mechanism from variable policy instruments, and introduction of new research paradigm. This research provides a theoretical reference for the research and decision-making of the innovation incentive policy in the pharmaceutical industry. |
Key words:Pharmaceutical industry Innovation Incentive Regulation Policy |
摘要点击次数: 1816 全文下载次数: 10 |
|
|
|
|
|